Saudi Arabia SFDA registration ME0000003094SFDAA00055
LIAISON Control Toxo IgG II
Saudi Arabia·Chemicals·DiaSorin S.p.A.·Annex II List BActiveProduct information
IVD Toxo IgG II Controls to be used for checking reliability of assay runs
Product use
The LIAISON® Control Toxo IgG II controls (310781) are to be used in LIAISON® chemiluminescent
immunoassay (CLIA) for checking reliability of assay runs. The performance characteristics of LIAISON® controls have not been established for any other assays or instrument platforms.
Device classification
- Risk Class
- Annex II List B
- Product Category
- Chemicals
- Product Type
- IVD
Registration information
- Registration ID
- ME0000003094SFDAA00055
- Authorization ID
- MDMA-1-2019-4213
- Status
- Active
- Expire Date
- May 26, 2025
Manufacturer
- Manufacturer Name
- DiaSorin S.p.A.
Model information
- Model ID(s)
- 310781
Product accessories
[]
About this record
Access comprehensive regulatory information for LIAISON Control Toxo IgG II in the Saudi Arabia medical device market through Pure Global AI's free database. This Annex II List B device is registered with Saudi Arabia SFDA under registration number ME0000003094SFDAA00055 and manufactured by DiaSorin S.p.A..
This page provides complete registration details including product category (Chemicals), manufacturer information, model details, and regulatory compliance data from the official Saudi Arabia SFDA medical device database. Pure Global AI offers free access to Saudi Arabia's complete medical device registry, helping global MedTech companies navigate SFDA regulations efficiently.
Free DatabasePowered by Pure Global AISFDA Official DataAnnex II List B